Appistry

About Appistry

Established in 2001 and headquartered in St. Louis, Missouri, Appistry began its journey as a cloud infrastructure software provider, developing a product suite known as the CloudIQ Platform. This platform was designed to offer enterprises a scalable and fault-tolerant solution for managing applications and large datasets across private and hybrid cloud environments, attracting clients like FedEx and Northrop Grumman.

A significant transformation occurred when Kevin Haar, a veteran of growth organizations like Rational Software, joined as President and CEO. Recognizing the company was adrift in a crowded analytics market, Haar spearheaded a strategic pivot into the genomics and biotechnology sector. This new direction was a natural fit for the company's big data management expertise and its location in St. Louis. Under this new vision, Appistry transitioned from a general technology provider to a customer-driven company focused on building specific applications for the life sciences market, aiming to bridge the gap between complex genomic data and actionable health outcomes.

The company's offerings evolved to cater to researchers and clinicians. It developed Ayrris, a product that integrated next-generation sequencing (NGS) analysis tools into a single, scalable platform. Appistry also launched CloudDx, a web-based platform that enabled physicians, particularly those at smaller institutions, to order and access complex genomic tests from leading developers. These bioinformatics tools were designed to simplify data analysis for users without a deep computational background, automating workflows and helping to turn raw genomic data into intelligence for clinical decision-making. Revenue was generated through subscriptions to its software and platform services.